Search Results - "RANSOHOFF, R. M"

Refine Results
  1. 1

    Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function by KHARRI, B. O, MAN, S, DUDA, P. W, PANZARA, M. A, RANSOHOFF, R. M, FOX, R. J, GIOVANNONI, G, KOO, A. P, LEE, J.-C, TUCKY, B, LYNN, F, JURGENSEN, S, WOODWORTH, J, GOELZ, S

    Published in Neurology (03-02-2009)
    “…Accelerating the clearance of therapeutic monoclonal antibodies (mAbs) from the body may be useful to address uncommon but serious complications from…”
    Get full text
    Journal Article
  2. 2

    The Chemokine System in Neuroinflammation: An Update by Ransohoff, R. M.

    Published in The Journal of infectious diseases (01-12-2002)
    “…Chemokines and their receptors govern physiologic and pathologic leukocyte trafficking. The function of the chemokine system may be of particular interest for…”
    Get full text
    Journal Article Conference Proceeding
  3. 3
  4. 4

    Fatal PML associated with efalizumab therapy: Insights into integrin αLβ2 in JC virus control by SCHWAB, N, ULZHEIMER, J. C, BRÜCK, W, TOYKA, K. V, RANSOHOFF, R. M, WIENDL, H, FOX, R. J, SCHNEIDER-HOHENDORF, T, KIESEIER, B. C, MONORANU, C. M, STAUGAITIS, S. M, WELCH, W, JILEK, S, DU PASQUIER, R. A

    Published in Neurology (14-02-2012)
    “…Progressive multifocal leukoencephalopathy (PML) has become much more common with monoclonal antibody treatment for multiple sclerosis and other…”
    Get full text
    Journal Article
  5. 5

    A case of multiple sclerosis presenting with inflammatory cortical demyelination by POPESCU, B. F. Gh, BUNYAN, R. F, PARISI, J. E, RANSOHOFF, R. M, LUCCHINETTI, C. F

    Published in Neurology (17-05-2011)
    “…To describe a patient presenting with a clinically silent, incidentally found, and pathologically confirmed active demyelinating solitary cortical lesion…”
    Get full text
    Journal Article
  6. 6

    CSF Neutrophils Are Implicated in the Development of Vasospasm in Subarachnoid Hemorrhage by Provencio, J. J., Fu, X., Siu, A., Rasmussen, P. A., Hazen, S. L., Ransohoff, R. M.

    Published in Neurocritical care (01-04-2010)
    “…Background Cerebral vasospasm is a significant cause of morbidity in patients after aneurysmal subarachnoid hemorrhage (aSAH). There are few effective…”
    Get full text
    Journal Article
  7. 7

    Cortical demyelination in PML and MS : Similarities and differences by MOLL, N. M, RIETSCH, A. M, RANSOHOFF, A. J, COSSOY, M. B, HUANG, D, EICHLER, F. S, TRAPP, B. D, RANSOHOFF, R. M

    Published in Neurology (29-01-2008)
    “…To characterize pathologic changes in the cerebral cortex of patients with multiple sclerosis (MS) and progressive multifocal leukoencephalopathy (PML)…”
    Get full text
    Journal Article
  8. 8

    Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses by Menetski, J, Mistry, S, Lu, M, Mudgett, J.S, Ransohoff, R.M, DeMartino, J.A, MacIntyre, D.E, Abbadie, C

    Published in Neuroscience (09-11-2007)
    “…Abstract Recent findings demonstrate that chemokines, and more specifically CC chemokine ligand 2 (CCL2 or monocyte chemoattractant protein-1), play a major…”
    Get full text
    Journal Article
  9. 9

    Three or more routes for leukocyte migration into the central nervous system by Ransohoff, Richard M, Kivisäkk, Pia, Kidd, Grahame

    Published in Nature reviews. Immunology (01-07-2003)
    “…Leukocyte migration into and through tissues is fundamental to normal physiology, immunopathology and host defence. Leukocyte entry into the central nervous…”
    Get full text
    Journal Article
  10. 10

    Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis by Huang, D R, Wang, J, Kivisakk, P, Rollins, B J, Ransohoff, R M

    Published in The Journal of experimental medicine (19-03-2001)
    “…Monocyte chemoattractant protein (MCP)-1 plays a critical role in innate immunity by directing the migration of monocytes into inflammatory sites. Recent data…”
    Get full text
    Journal Article
  11. 11

    Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a by RUDICK, R. A, PACE, A, GALETTA, S. L, LUBLIN, F. D, RADUE, E.-W, RANSOHOFF, R. M, RANI, M. R. S, HYDE, R, PANZARA, M, APPACHI, S, SHROCK, J, MAURER, S. L, CALABRESI, P. A, CONFAVREUX, C

    Published in Neurology (09-06-2009)
    “…Findings from a small clinical study suggested that statins may counteract the therapeutic effects of interferon beta (IFNbeta) in patients with…”
    Get full text
    Journal Article
  12. 12

    Axonal Transection in the Lesions of Multiple Sclerosis by Trapp, Bruce D, Peterson, John, Ransohoff, Richard M, Rudick, Richard, Mörk, Sverre, Bö, Lars

    Published in The New England journal of medicine (29-01-1998)
    “…Multiple sclerosis is a disease of the central nervous system characterized by multicentric inflammation and destruction of myelin. The primary cause of…”
    Get full text
    Journal Article
  13. 13

    CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesions by Trebst, C, König, F, Ransohoff, RM, Brück, W, Stangel, M

    Published in Multiple sclerosis (01-07-2008)
    “…Remyelination in multiple sclerosis (MS) occurs spontaneously and extensively. The underlying mechanisms, however, are only partly understood. Findings in…”
    Get full text
    Journal Article
  14. 14

    In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis by RUDICK, R. A, RANSOHOFF, R. M, LEE, J.-C, PEPPLER, R, YU, M, MATHISEN, P. M, TUOHY, V. K

    Published in Neurology (01-05-1998)
    “…Recombinant interferon beta (IFNbeta) benefits patients with relapsing remitting multiple sclerosis (MS), but the mechanisms of action are unknown. We studied…”
    Get full text
    Journal Article
  15. 15

    Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis by Sørensen, T. L., Ransohoff, R. M., Strieter, R. M., Sellebjerg, F.

    Published in European journal of neurology (01-07-2004)
    “…The chemokine monocyte chemoattractant protein (MCP)‐1/CCL2 and its receptor CCR2 have been strongly implicated in disease pathogenesis in experimental…”
    Get full text
    Journal Article
  16. 16

    Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis by Glabinski, AR, Tani, M, Strieter, RM, Tuohy, VK, Ransohoff, RM

    Published in The American journal of pathology (01-02-1997)
    “…Chemokines are secreted peptides that exhibit selective chemoattractant properties for target leukocytes. Two subfamilies, alpha- and beta-chemokines, have…”
    Get full text
    Journal Article
  17. 17

    Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis by Sørensen, T. L., Sellebjerg, F., Jensen, C. V., Strieter, R. M., Ransohoff, R. M.

    Published in European journal of neurology (01-11-2001)
    “…Studies of chemokines in cerebrospinal fluid (CSF) of patients with active multiple sclerosis (MS) have indicated that specific chemokines may have important…”
    Get full text
    Journal Article
  18. 18

    Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia by Biber, K, Dijkstra, I, Trebst, C, De Groot, C.J.A, Ransohoff, R.M, Boddeke, H.W.G.M

    Published in Neuroscience (01-01-2002)
    “…It has been established recently that inflammation of the CNS is accompanied by an expression of chemokines within the CNS. Several lines of evidence suggest…”
    Get full text
    Journal Article
  19. 19

    Axon Loss in the Spinal Cord Determines Permanent Neurological Disability in an Animal Model of Multiple Sclerosis by WUJEK, JEROME R, BJARTMAR, CARL, RICHER, EDWARD, RANSOHOFF, RICHARD M, YU, MIN, TUOHY, VINCENT K, TRAPP, BRUCE D

    “…Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Most patients undergo an initial relapsing-remitting…”
    Get full text
    Journal Article
  20. 20

    Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation? by RANSOHOFF, R. M, TANI, M

    Published in Trends in neurosciences (Regular ed.) (01-04-1998)
    “…Hematogenous leukocytes infiltrate the CNS after inflammatory stimuli, including infection, mechanical trauma and excitotoxic neuronal necrosis. However,the…”
    Get full text
    Journal Article